Health Jan 14 At $850,000, price for new childhood blindness gene therapy four times too high, analysis says By Andrew Joseph, STAT
Health Oct 15 We may soon have our first $1 million drug. Who will pay for it? And how? As the first gene therapies approach the market, drug makers, insurers, and patients are debating complex questions about cost, value, and payment plans. By Meghana Keshavan, STAT